Zevra Therapeutics, Inc. ZVRA Business Segments — Investment Income, Interest
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s business segments — investment income, interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s business segments — investment income, interest?
- Zevra Therapeutics, Inc. (ZVRA) reported business segments — investment income, interest of $2.18M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s business segments — investment income, interest changed year-over-year?
- Zevra Therapeutics, Inc.'s business segments — investment income, interest increased by 204.2% year-over-year, from $718K to $2.18M.
- What does business segments — investment income, interest mean?
- Represents interest income earned on cash balances, short-term investments, or other financial assets held by the segment. This metric highlights the segment's ability to generate non-operating returns from its liquid capital resources.